Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Submucosal tramadol and lidocaine to improve inferior alveolar nerve block success in mandibular molars with symptomatic irreversible pulpitis
TCTR20190509004Completed
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tramadol and lidocaine in irreversible pulpitis, sponsored by none. Primary endpoint: Success rate of inferior alveolar nerve block. Started Nov 2018; status: completed.
02
Drugs
tramadollidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on TCTR20190509004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190509004.